TMEM106A's function might be co‐opted in gliomas to promote tumor aggressiveness, possibly through pathways that are dormant in other tissues of its microenvironment (i.e., immune cells) rather than directly impacting the tumor cells themselves. The gene discussed is TMEM106A; the disease is glioma.